Research explores the connection between aging populations and oral health, proposing an integrated model to address health challenges in older adults, with a focus on policy changes in the UK.
China NMPA accepts Astellas BLA of zolbetuximab
Zolbetuximab is intended for treating patients with HER2-negative gastric or gastroesophageal junction adenocarcinoma. Credit: meeboonstudio/Shutterstock.com. The Center for Drug Evaluation (CDE) of the China National